Oral Anticoagulant Use in Patients with Non Valvular Atrial Fibrillation: Analysis of Electronic Medical Record Data

Study type

• Study type:
  Non-interventional study
• Scope of the study:
  Drug utilisation

  Effectiveness study (incl. comparative)

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Name of medicine:
  ELIQUIS

  XARELTO

  PRADAXA
• Name of medicine, other:
  Coumadin
• Medical condition to be studied:
  Atrial fibrillation

Population studied

• Age groups:
  Adults (18 to < 46 years)

  Adults (46 to < 65 years)

  Adults (65 to < 75 years)

  Adults (75 to < 85 years)

  Adults (85 years and over)
• Estimated number of subjects:
  20000

Study design details

• Main study objective:
  Investigation of safety and effectiveness outcomes for NVAF patients taking OACs.
• Outcomes:
  Bleeding, stroke, embolism
• Data analysis plan:
  Propensity score matching will be conducted. Standard statistical measures will be calculated (e.g. mean, median, mode) along with hazard ratios.